ABSTRACT A double-blind within-patient investigation was performed to determine whether the interposition of an extension tube (10 cm length x 3 -2 cm diameter) between a metered dose inhaler and the mouth alters the bronchodilator efficacy of terbutaline sulphate. On two consecutive study days 14 adult patients with stable reversible airways obstruction inhaled a cumulative dose of 500 jig of terbutaline which was delivered from a metered dose inhaler with or without the extension tube attached and received placebo in a similar manner. The drug was inhaled in doses of 125, 125, and 
Pressurised aerosols provide a convenient and rapid method of delivery of drugs into the airways. One of the practical disadvanta-ges associated with the use of freon propelled inhalers is that 70-90% of the dose impacts on the oropharynx, and is subsequently swallowed.1 2 Even if the technique of administration is optimum, only 10% of the drug enters the airways. A method recommended to overcome aerosol deposition in the mouth has been to hold the canister a short distance from the widely open mouth.3 Studies by Mor6n4 have shown that the interposition of an extension tube (10 cm length x 3X2 cm diameter) between the mouth and a metered dose inhaler reduces significantly the total "loss" of drug in the mouth and tube-that is, from 53-9% to 39-6%-thus indicating the possibility of increasing the availability of the drug within the lungs and hence improving its therapeutic effect. It is quantitatively difficult to assess the amount of aerosol which enters the lungs but a dose-related bronchodilattor effect can be assessed by the degree of relief of airways obstruction. The present study was designed to assess the therapeutic benefits that may be derived from *the addition of an extension tube (spacer) to a metered dose inhaler in the administration of terbutaline sulphate.
Methods
The study was performed on 14 adult patients (nine male and five female) whose clinical details are summarised in table 1. Their ages ranged from 19 to 66 years. Nine of the subjects had asthma, three had chronic bronchitis, and two showed features of chronic bronchitis and late onset asthma. Nine patients were non-smokers and five were either current smokers or had only discontinued the habit in the last 12 months. All the patients gave informed consent. Subjects were excluded if they had significant bronchopulmonary disease other than asthma or chronic bronchitis, or had evident disease in any other Effect of an extension tube on the bronchodilator efficacy of terbutaline 10 the size of the particles inhaled," and abnormalities in airways structure.'2 13 The aim of the present study was to alter the mode of inhalation by t;he use of an extension tube, thus decreasing the deposition of the drug within the oral cavity and perhaps allowing more Table 3 Mean decrease in TGV (I) (±SD) and mean increase in sGaw (kPa-'s-') for 14 patients after inhaling terbutaline drug to enter the airways. The current method of using metered dose inhalers is for each puff to be deeply inhaled and the breath to be held afterwards. The following factors during inhalation influence the effect of the drug within the lung: firstly, a high flow rate during inspiration reduces penetrance because of impaction of particles within the mouth and large airways14 15; secondly, with increasing inspired volume drug penetrance is increased at a constant flow rate13 and breath-holding after inspiration allows the pariticles within the airways to settle by gravity. '6 Mor6n4 concluded that an extension tube attached to an inhaler decreased deposition of aerosol droplets within the mouth by reducing the velocity of particles emitted from the tube, increasing the time for evaporation, and thereby reducing droplet size and allowing better distribution of particles within the airways.
The bronohodilator efficacy of terbutaline in our study was neither impai-ed nor increased by the use of the tube spacer. A,possible reason for the lack of improvement is that 10 group.bmj.com on June 23, 2017 -Published by http://thorax.bmj.com/ Downloaded from S A Gomm, N P Keaney, N J P Winsey, and T B Stretton to see whether the introduction of an extension tube is beneficial for asthmatic paitients who have troublesome pharyngeal moniliasis when receiving maintenance corticosteroid aerosol therapy.
